The new definition’s interpretation of “intervention” and “outcome” could apply even to studies of basic biological mechanisms.   The U.S. National Institutes o...

Mixed experience but no changes in the forecast Twenty years after its inception, the FDA’s Fast Track designation program is going strong, with many signs that it ha...

Worldwide Clinical Trials’ Director of Global Patient Recruitment and Retention, Barbara Zupancic, will present “Improving Patient Engagement in Alzheimer’s Disease T...

Worldwide Clinical Trials will host the next in its series of ‘Eavesdropping on the Experts’ webinars titled, Five Emerging Trends in Cardiovascular Research” on Sept...

A new study from the University of North Carolina at Chapel Hill finds beta blockers are not needed after a heart attack if heart-attack survivors are taking ACE inhi...

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ...

To advance exploration of uncommon approaches to clinical research and development challenges, Worldwide Clinical Trials (www.worldwide.com) will host the next in its...